After an existing research facility sustained damage during a torrential rain storm, Architecture, Inc. partnered with SRI to add flexibility to the lab’s operations, and to prepare it for future growth. The lab focuses on drug and vaccine discovery and development for commercial and government clients. It also conducts a high volume of antiviral screens against a variety of viruses for pharmaceutical companies, biotech firms, small labs, academic groups, and startups. As part of the 16,000 sf repair project, the back corner of the building was demolished and completely rebuilt. Other design work included restoration of structure to safe condition and the design and installation of HVAC systems that conformed to CDC and NIH guidelines.